Literature DB >> 17045387

Unexpected insights into pelvic function following phosphodiesterase manipulation--what's next for urology?

Kevin T McVary.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 17045387     DOI: 10.1016/j.eururo.2006.09.014

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  6 in total

Review 1.  A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction.

Authors:  Konstantinos Hatzimouratidis
Journal:  Ther Adv Urol       Date:  2014-08

Review 2.  The role of phosphodiesterase-5 inhibitors in prostatic inflammation: a review.

Authors:  Christina Alves Peixoto; Fabiana Oliveira Dos Santos Gomes
Journal:  J Inflamm (Lond)       Date:  2015-09-15       Impact factor: 4.981

3.  Tadalafil vs. tamsulosin in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a prospective, randomized study.

Authors:  Vedamurthy Reddy Pogula; Lalith Sagar Kadiyala; Vijayabhaskar Reddy Gouru; Sivasankar Reddy Challa; Ranadheer Byram; Sudeep Bodduluri
Journal:  Cent European J Urol       Date:  2019-03-14

4.  Tadalafil monotherapy in management of chronic prostatitis/chronic pelvic pain syndrome: a randomized double-blind placebo controlled clinical trial.

Authors:  Ahmed M Tawfik; Mohammed H Radwan; Mohammed Abdulmonem; Mohammed Abo-Elenen; Samir A Elgamal; Mohammed O Aboufarha
Journal:  World J Urol       Date:  2022-07-08       Impact factor: 3.661

Review 5.  Lower urinary-tract symptoms and testosterone in elderly men.

Authors:  Aksam A Yassin; Ahmed I El-Sakka; Farid Saad; Louis J G Gooren
Journal:  World J Urol       Date:  2008-07-02       Impact factor: 4.226

Review 6.  Effects of testosterone on the lower urinary tract go beyond the prostate: New insights, new treatment options.

Authors:  Farid Saad; Aksam A Yassin; Ahmad Haider; Louis Gooren
Journal:  Arab J Urol       Date:  2011-09-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.